A meta-analysis on DPP-4i used as intervention therapy in 253 diagnosed T1D patients pooled from 5 randomized controlled trials showed a trend to decrease in HbA1c levels and improvement in insulin demands and glycemic control (Wang et al, 2018). This evidence concerns the gene INS and type 1 diabetes mellitus.